Ephrin-B2–Activated Peripheral Blood Mononuclear Cells From Diabetic Patients Restore Diabetes-Induced Impairment of Postischemic Neovascularization

We hypothesized that in vitro treatment of peripheral blood mononuclear cells (PB-MNCs) from diabetic patients with ephrin-B2/Fc (EFNB2) improves their proangiogenic therapeutic potential in diabetic ischemic experimental models. Diabetes was induced in nude athymic mice by streptozotocin injections...

Descripción completa

Detalles Bibliográficos
Autores principales: Broquères-You, Dong, Leré-Déan, Carole, Merkulova-Rainon, Tatiana, Mantsounga, Chris S., Allanic, David, Hainaud, Patricia, Contrères, Jean-Olivier, Wang, Yu, Vilar, José, Virally, Marie, Mourad, Jean-Jacques, Guillausseau, Pierre-Jean, Silvestre, Jean-Sébastien, Lévy, Bernard I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447889/
https://www.ncbi.nlm.nih.gov/pubmed/22596048
http://dx.doi.org/10.2337/db11-1768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447889/
https://www.ncbi.nlm.nih.gov/pubmed/22596048
http://dx.doi.org/10.2337/db11-1768

Ejemplares similares